🇺🇸 FDA
Patent

US 9535076

Methods and compositions for eliciting an amyloid-selective immune response

granted A61KA61K2039/55505A61K2039/55566

Quick answer

US patent 9535076 (Methods and compositions for eliciting an amyloid-selective immune response) held by The Regents of the University of California expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/55505, A61K2039/55566, A61K2039/60, A61K39/0007